Latest treatment news and information for patient advocates and people working in hepatitis in Europe. Find out more about infohep > infohep is produced by NAM. Find out more about NAM www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330// Dr Kosh Agarwal discusses results of the REEF-2 study at the International LIver Congress. Photo © Steve Forrest & Andrew McConnell / EASL.News from the International Liver Congress 2022Experimental hepatitis B combination suppresses key marker but fails to achieve functional cure. New & experimental hepatitis B treatmentsBepirovirsen suppresses hepatitis B surface antigen, moves forward to larger functional cure studies. Professor Heiner Wedemeyer of Hannover Medical School speaking at an International Liver Congress press conference. Photo © Steve Forrest & Andrew McConnell / EASL.Hepatitis DBulevirtide leads to sustained improvement for people with hepatitis D. FactsheetsRead our updated hepatitis C treatment factsheets on infohep. Hepatitis bulletinSign up for our monthly hepatitis bulletin. New to hepatitis?Read our introductory information on viral hepatitis > infohep news Bepirovirsen suppresses hepatitis B surface antigen, moves forward to larger functional cure studies Keith Alcorn / 29 June 2022 Bepirovirsen, an experimental drug with a novel mode of action, suppressed hepatitis B surface antigen below the limits of detection in approximately 30% of patients after 24 weeks of treatment and ... Bulevirtide leads to sustained improvement for people with hepatitis D Liz Highleyman / 28 June 2022 The entry inhibitor bulevirtide (Hepcludex) led to a reduction in hepatitis delta virus (HDV) viral load, lower liver enzyme levels and improvement in fibrosis after 48 weeks of follow-up, according to findings ... New and experimental treatments for hepatitis B Experimental hepatitis B combination suppresses key marker but fails to achieve functional cure Keith Alcorn / 27 June 2022 People with hepatitis B who received a combination of experimental drugs as well as their standard treatment for 48 weeks were significantly less likely to have high levels of hepatitis B surface ... Treatment for previous non-responders & relapsers Re-treatment of hepatitis C is highly effective after the first combination fails Keith Alcorn / 24 June 2022 Two combinations proved highly effective in curing hepatitis C in people who had experienced the failure of a previous combination containing an NS5A inhibitor, studies in Europe and New Zealand show. The findings, ... Treatment in liver transplanted Short-course treatment prevents hepatitis C after organ transplant Keith Alcorn / 24 June 2022 A seven-day course of direct-acting antiviral treatment started hours before an organ transplant prevented hepatitis C infection in everyone who received a transplant from a donor with hepatitis C, researchers from the Mayo ... View all infohep news Editors' picks from other sources WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics World Health Organization / 24 June 2022 Acute hepatitis outbreak swells to nearly 900 cases; global data shows ‘mixed picture’ Healio / 24 June 2022 GPs could initiate treatment for chronic hepatitis C, say researchers Pulse / 03 June 2022 U.S. reports 180 cases of unexplained hepatitis in children, as researchers investigate potential causes STAT / 23 May 2022 CDC investigating 109 unusual hepatitis cases in kids in outbreak STAT / 09 May 2022 Ensuring high-quality viral hepatitis care for refugees from Ukraine EASL / 04 May 2022 Hepatitis cases detected in children in Europe and the US BBC / 20 April 2022 Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland World Health Organization / 20 April 2022 1.2 million initiated DAA treatment for HCV between 2014 and 2020 Healio / 13 April 2022 Hepatitis C widespread but rarely treated in postpartum Medicaid beneficiaries with opioid use disorder University of Pittsburgh / 13 April 2022 View all news from other sources Latest library resources Safer heroin injecting TypeWeb page Published2013 AuthorJon Derricott A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel [2012] TypeWeb page CountryRussian Federation, Turkey, Western and Central Europe Published2013 AuthorLiver International Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 TypeWeb page CountryUnited States PublishedApril 2013 AuthorAmerican Association for the Study of Liver Diseases View all resources Looking for country specific news and resources?Visit our country information pages > Keep up to date with the latest hepatitis newsSign up for our free monthly email bulletin >